e-learning
resources
Paris 2018
Sunday, 16.09.2018
COPD phenotypes: a1 antitrypsin deficiency and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical phenotyping of COPD patients: a simple tool with prognosis value
A. Ben Saad (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), S. Mhamed (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia)
Source:
International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Session:
COPD phenotypes: a1 antitrypsin deficiency and beyond
Session type:
Poster Discussion
Number:
575
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ben Saad (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), S. Mhamed (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia). Clinical phenotyping of COPD patients: a simple tool with prognosis value. 575
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
Clinical prognostic tools and their use in COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
COPD: implementing biomarkers to improve prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021
COPD: algorithms and clinical management
Source: Eur Respir J, 50 (5) 1701733; 10.1183/13993003.01733-2017
Year: 2017
Simple functional performance tests as predictors of clinical outcomes in COPD
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Determining the best diagnostic biomarker for sepsis and prognosis assessment
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Development and validation of a simple tool for clinical assessment of patients treated with home NIV: The S3-NIV questionnaire
Source: International Congress 2017 – New insights in chronic respiratory failure
Year: 2017
Is FEV1/FEV6 ratio a reliable tool in COPD diagnosis ?
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Clinical clustering of COPD patients is useful to predict future COPD exacerbations
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
A simple algorithm for the identification of clinical COPD phenotypes
Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017
Year: 2017
The new prognostic multidimensional index HODEH in patient with COPD
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Clinical features and functional parameters predict the probability of ACO in patients with asthma and COPD
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Useful malnutrition diagnostic criteria for stable COPD in Japanese patients
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis?
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017
A network-based approach to defining phenotypes in COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept